Cognitive and vascular (dys)function after COVID-19
- PMID: 40952641
- DOI: 10.1007/s13365-025-01276-5
Cognitive and vascular (dys)function after COVID-19
Abstract
COVID-19 is a systemic infection that causes endothelial dysfunction, contributing to severe cases. While vascular complications are well-documented, their impact on vascular structure, function, and cognition remains unclear. This cross-sectional study explored vascular and cognitive differences across patients with mild, moderate, and severe COVID-19, examining correlations between global cognitive performance and vascular parameters. This study included 83 working-age patients (30-65 years, both sexes) who recovered from COVID-19 within 6-12 months. They were grouped by severity: mild (outpatients, no oxygen support), moderate (hospitalized, conventional oxygen therapy), and severe (hospitalized, advanced oxygen therapy). Exclusions included pre-existing cognitive or neurological conditions, significant atherosclerosis, malignancies, and prior COVID-19 vaccination. Global cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) test, while vascular parameters - carotid intima-media thickness (IMT), beta stiffness index (β index), mean flow velocity (MVs), maximum velocity after breath-holding (MV-BH), and breath-holding index (BHI) - were evaluated using duplex ultrasound and transcranial Doppler. Patients with severe COVID-19 had the highest carotid stiffness and poorest cerebrovascular reactivity. While MoCA scores showed no significant group differences, 23-40% had mild cognitive impairment. MoCA scores negatively correlated with β index in mild group (ρ=--0.453; p = 0.034), while MVs positively correlated with MoCA in severe cases (ρ = 0.414; p = 0.028). The association between arterial stiffness and cognitive impairment in mild cases, suggests lasting effects of SARS-CoV-2 rather than pre-existing conditions. These findings highlight carotid stiffness as a key factor in post-COVID-19 cognitive impairment, emphasizing early risk identification for timely intervention.
Keywords: Breath holding index; Carotid stiffness; Cerebrovascular reactivity; Cognition; SARS-CoV-2; Β index.
© 2025. The Author(s) under exclusive licence to The Journal of NeuroVirology, Inc.
Conflict of interest statement
Declarations. Ethical approval: The study was approved by the Ethics Committee of the University Clinical Center of Vojvodina (approval number 00-421/2020). All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with 1964. Helsinki Declaration and its later amendments or comparable ethical standards. Consent to participate: Informed written consent was obtained from all participants included in the study. Competing interests: The authors declare no competing interests. Data sharing statement: The data supporting the findings of this study are available from the corresponding author upon reasonable request. Clinical trial number: Not applicable.
References
-
- Aderinto N, Olatunji G, Kokori E et al (2025) COVID-19 and cognitive impairment: a review of the emerging evidence. Discov Ment Health 5:56. https://doi.org/10.1007/s44192-025-00189-3 - DOI - PubMed - PMC
-
- Anwar Garcia Santos R, Rodriguez Rodriguez M, Rodriguez Cruces R (2021) Neuropsychiatric symptoms in post COVID-19. J Neurol Sci 429:119828. https://doi.org/10.1016/j.jns.2021.119828 - DOI - PMC
-
- Arbula S, Pisanu E, Bellavita G et al (2024) Insights into attention and memory difficulties in post-COVID syndrome using standardized neuropsychological tests and experimental cognitive tasks. Sci Rep 14:4405. https://doi.org/10.1038/s41598-024-54613-9 - DOI - PubMed - PMC
-
- Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, Wisniwesky JP (2021) Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open 4:e2130645. https://doi.org/10.1001/jamanetworkopen.2021.30645 - DOI - PubMed - PMC
-
- Checa A, Navas E, Valencia V, Alcivar J (2022) Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador. Rev Mex Neuroci 23:126–129. https://doi.org/10.24875/rmn.21000060 - DOI
Grants and funding
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
- 142-451-3523/2023-01/Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
LinkOut - more resources
Full Text Sources
Miscellaneous
